FABIANI & COMPANY ON BEHALF OF CLINICAL DATA, INC.

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2009–2010

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2010	—	4	1
2009	—	5	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
MARTIN GREEN	—	9

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	8
SENATE	8
Defense, Dept of (DOD)	4

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	9
Health Issues	Health Issues	8
Defense	Defense	4
Budget/Appropriations	Budget/Appropriations	1

Bills Explicitly Cited (6)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

S. 976110th Congress

Genomics and Personalized Medicine Act of 2007

2009 · third_quarter · Firm: MARTIN GREEN

Open original LDA filing ↗

Cited source text and reported amounts

S. 976, the Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations

Client expense: — · Firm income: —

Matched citations: S. 976

S. 976110th Congress

Genomics and Personalized Medicine Act of 2007

2009 · third_quarter · Firm: MARTIN GREEN

Open original LDA filing ↗

Cited source text and reported amounts

S. 976, the Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations

Client expense: — · Firm income: —

Matched citations: S. 976

S. 976110th Congress

Genomics and Personalized Medicine Act of 2007

2009 · second_quarter · Firm: MARTIN GREEN

Open original LDA filing ↗

Cited source text and reported amounts

S. 976, the Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations

Client expense: — · Firm income: —

Matched citations: S. 976

S. 976110th Congress

Genomics and Personalized Medicine Act of 2007

2009 · second_quarter · Firm: MARTIN GREEN

Open original LDA filing ↗

Cited source text and reported amounts

S. 976, the Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations

Client expense: — · Firm income: —

Matched citations: S. 976

Show 2 more cited filings

S. 976110th Congress

Genomics and Personalized Medicine Act of 2007

2009 · first_quarter · Firm: MARTIN GREEN

Open original LDA filing ↗

Cited source text and reported amounts

S. 976, the Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations

Client expense: — · Firm income: —

Matched citations: S. 976

S. 976110th Congress

Genomics and Personalized Medicine Act of 2007

2009 · first_quarter · Firm: MARTIN GREEN

Open original LDA filing ↗

Cited source text and reported amounts

S. 976, the Genomics and Personalized Medicine Act of 2007, Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations

Client expense: — · Firm income: —

Matched citations: S. 976

Source: Senate LDA

FABIANI & COMPANY ON BEHALF OF CLINICAL DATA, INC. — Lobbying Disclosure | Poliscope